(Q35168573)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1283984%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

title

Antithyroid drug and Graves' hyperthyroidism. Significance of treatment duration and TRAb determination on lasting remission (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1283984%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

author

Ricardo V. García-Mayor

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1283984%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

author name string

C Páramo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1283984%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

R Luna Cano

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1283984%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

L F Pérez Mendez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1283984%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

J C Galofré

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1283984%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

A Andrade

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1283984%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

publication date

1 December 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1283984%20AND%20SRC:MED&resulttype=core&format=json

Journal of Endocrinological Investigation

13 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1283984%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1283984%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1283984%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

page(s)

815-820

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1283984%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf03348811

13 September 2019

exact match

0 references

cites work

Hyperthyroidism in children treated with long term medical therapy: twenty-five percent remission every two years.

1 reference

https://api.crossref.org/works/10.1007%2FBF03348811

Antithyroid Drugs and Graves' Disease: A Prospective Randomized Evaluation of the Efficacy of Treatment Duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348811

HLA-DR3 and HLA-DR5 Associated Thyrotoxicosis-Two Different Types of Toxic Diffuse Goiter*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348811

Comparison of Effects of High and Low Dosage Regimens of Antithyroid Drugs in the Management of Graves’ Hyperthyroidism*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348811

Evidence for an effect of antithyroid drugs on the natural history of Graves' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348811

Value of thyroid-stimulating-antibody determinations in predicting short-term thyrotoxic relapse in Graves' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348811

Long-term Antithyroid Treatment in Hyperthyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348811

Short-Term Antithyroid Drug Therapy for the Thyrotoxicosis of Graves's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348811

Optimum duration of antithyroid drug treatment determined by assay of thyroid stimulating antibody in patients with Graves' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348811

Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies

21 January 2018

1 reference

12 December 2020

Prediction of outcome in Graves' disease after carbimazole treatment.

1 reference

12 December 2020

Antithyroid drugs in the treatment of hyperthyroidism of Graves' disease: long-term follow-up of 434 patients. Scottish Automated Follow-Up Register Group

1 reference

12 December 2020

Long-term outcome of hyperthyroidism treated with antithyroid drugs

1 reference

12 December 2020

Prediction of relapse in hyperthyroid Graves' disease

1 reference

12 December 2020

Changes in thyroid-stimulating antibody activity in Graves' disease treated with antithyroid drug and its relationship to relapse: a prospective study

1 reference

12 December 2020

Thyroid clinical dysfunction in patients chronically treated with amiodarone

1 reference

12 December 2020

Thyroid stimulating antibodies: an aid to the strategy of treatment of Graves' disease?

1 reference

12 December 2020

Thionamide therapy in Graves' disease: relation of relapse rate to duration of therapy

1 reference

12 December 2020

Thyroid Suppression Test and Outcome of Hyperthyroidism Treated with Antithyroid Drugs and Triiodothyronine

1 reference

12 December 2020

Factors influencing the outcome of thyrostatic drug therapy in Graves' disease

1 reference

12 December 2020

Statistical methods applied to the clinical diagnosis of thyrotoxicosis

1 reference

12 December 2020

Follow-Up Comparison of Short-TermVersus1-Year Antithyroid Drug Therapy for the Thyrotoxicosis of Graves' Disease*

1 reference

12 December 2020

Goitre size and outcome of medical treatment of Graves' disease

1 reference

12 December 2020

The ability of the serum thyrotrophin receptor antibody (TRAb) index and HLA status to predict long-term remission of thyrotoxicosis following medical therapy for Graves' disease

1 reference

12 December 2020

Low remission after therapy for Graves disease. Possible relation of dietary iodine with antithyroid therapy results

1 reference

12 December 2020

Changes in Thyroid-Stimulating Immunoglobulins during Antithyroid Therapy*

1 reference

12 December 2020

Carbimazole and the Autoimmune Response in Graves' Disease

1 reference

12 December 2020

Early remission in thyrotoxicosis produced by short courses of treatment

1 reference

12 December 2020

The management of hyperthyroidism due to Graves' disease in Europe in 1986. Results of an international survey

1 reference

12 December 2020

Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease.

1 reference

12 December 2020

Serum triiodothyronine to thyroxine ratio: a newly recognized predictor of the outcome of hyperthyroidism due to Graves' disease

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03348811

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1283984%20AND%20SRC:MED&resulttype=core&format=json

release_vwcwd3xikbg35fj765bzflpolm

13 September 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vwcwd3xikbg35fj765bzflpolm

24 November 2022

mapped directly with Wikidata item

1 reference